Gout – Epidemiology – Epidemiology Dashboard

Clarivate Epidemiology’s coverage of gout comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of gout for each country, as well as annualized case counts projected to the national population.

Clarivate Epidemiology will answer the following questions:

  • Of all people with gout, how many in each of the major mature pharmaceutical markets have been formally diagnosed?
  • Of all people diagnosed with gout, how many in each of the major mature pharmaceutical markets are drug-treated?
  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of gout over the forecast period?

All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

In addition to the total number of cases for each forecast year, Clarivate Epidemiology provides at least 10 years of forecast data for the following subpopulations:

  • Total prevalent cases of gout by diagnosis status.
  • Diagnosed prevalent cases of gout by drug-treatment status.

Note: Coverage may vary by country.